Boothbay Fund Management »

Ocuphire Pharma shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.4M 1.2M 4.55
2022-03-31 $39k 12k 3.28
2021-12-31 $44k 12k 3.70
2021-09-30 $61k 12k 5.13
2021-06-30 $71k 13k 5.30
2021-03-31 $78k 13k 5.83

More positions owned by Boothbay Fund Management

At&t Call Option (T)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Call Option (TSLA)
Abivax Sa Sponsored Ads (ABVX)
Ge Aerospace Com New Call Option (GE)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Cornerstone Strategic Value (CLM)
Mineralys Therapeutics Put Option (MLYS)
United Therapeutics Corporation Call Option (UTHR)
Constellation Brands Cl A Call Option (STZ)

View all positions for Boothbay Fund Management

Top funds holding Ocuphire Pharma

BIOS Capital Management
Balyasny Asset Management
Millennium Management
Vanguard Capital Management
Vanguard Group
ADAR1 Capital Management
Perceptive Advisors
Nantahala Capital Management
Woodline Partners
Boothbay Fund Management
Opaleye Management
Adage Capital Partners GP
Bleichroeder
Mink Brook Asset Management
Geode Capital Management

View all funds holding Ocuphire Pharma